PNC Financial Services Group
STLN

PNC Financial Services Group’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

PNC Financial Services Group’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.89K Buy
615
+453
+280% +$1.39K ﹤0.01% 4601
2025
Q4 		$577 Buy
162
+10
+7% +$37 ﹤0.01% 4802
2025
Q3 		$530 Buy
+152
New +$521 ﹤0.01% 4795

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's STLN Position: Q1 2026 in Review

PNC Financial Services Group increased its Starling Oncology Institute, Inc. Common Stock (STLN) stake by 280% in Q1 2026, buying an estimated $1.39K and bringing the position to 615 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #4601.

PNC Financial Services Group first reported a position in STLN in Q3 2025 and has held it in 3 quarters since. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • PNC Financial Services Group held 615 shares of Starling Oncology Institute, Inc. Common Stock worth $1.89K as of Q1 2026.
  • PNC Financial Services Group bought 453 Starling Oncology Institute, Inc. Common Stock shares in Q1 2026, an estimated $1.39K.
  • Starling Oncology Institute, Inc. Common Stock made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4601 holding.
  • PNC Financial Services Group first reported a position in Starling Oncology Institute, Inc. Common Stock in Q3 2025 and has held it in 3 quarters since.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.